CytRx Corporation (CYTR) Stock: Buying The Dip Isn’t A Bad Idea


CYTR Catalyst #2: July 12th Annual Meeting Of Shareholders

The second catalyst to watch out for with regard to CYTR is the coming annual meeting of shareholders. The meeting was disclosed yesterday in an SEC filing. Investors have been invited to the Hotel Bel Air in Los Angeles California to be part of the meeting. If you’d like more details on what will be discussed, click here.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on CYTR. In particular, we’re interested in both, the clinical data release and the result of the annual meeting, both of which could lead to incredible movement in the value of the stock. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

Previous Page | Catalyst 1 | Catalyst 2

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required


Please enter your comment!
Please enter your name here